Found: 28
Select item for more details and to access through your institution.
Inhibition of prostate cancer cell growth by 3',4',5'-trimethoxyflavonol (TMFol).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 47, doi. 10.1007/s00280-015-2746-3
- By:
- Publication type:
- Article
Comparison of saliva interleukin-2 concentration to the condition of gums in children with acute lymphoblastic leukaemia during anti-tumour treatment.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 205, doi. 10.1007/s00280-015-2750-7
- By:
- Publication type:
- Article
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomography.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A single-dose PK study of onapristone including the effect of food on absorption.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 171, doi. 10.1007/s00280-015-2754-3
- By:
- Publication type:
- Article
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 75, doi. 10.1007/s00280-015-2757-0
- By:
- Publication type:
- Article
Endometrial cancer: redefining the molecular-targeted approach.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 1, doi. 10.1007/s00280-015-2758-z
- By:
- Publication type:
- Article
Extension of the Calvert formula to patients with severe renal insufficiency.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 53, doi. 10.1007/s00280-015-2769-9
- By:
- Publication type:
- Article
Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 21, doi. 10.1007/s00280-015-2763-2
- By:
- Publication type:
- Article
Inhibition of prostate cancer cell growth by 3′,4′,5′-trimethoxyflavonol (TMFol).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 179, doi. 10.1007/s00280-015-2771-2
- By:
- Publication type:
- Article
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 105, doi. 10.1007/s00280-015-2772-1
- By:
- Publication type:
- Article
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 97, doi. 10.1007/s00280-015-2767-y
- By:
- Publication type:
- Article
A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 13, doi. 10.1007/s00280-015-2761-4
- By:
- Publication type:
- Article
Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 85, doi. 10.1007/s00280-015-2768-x
- By:
- Publication type:
- Article
Pilot study of modified FOLFOX6 adjuvant chemotherapy for high-risk rectal cancer treated with neoadjuvant chemoradiotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 29, doi. 10.1007/s00280-015-2764-1
- By:
- Publication type:
- Article
Direct and indirect targeting of MYC to treat acute myeloid leukemia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 35, doi. 10.1007/s00280-015-2766-z
- By:
- Publication type:
- Article
Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 163, doi. 10.1007/s00280-015-2773-0
- By:
- Publication type:
- Article
Development of a new equation to estimate creatinine clearance in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 117, doi. 10.1007/s00280-015-2777-9
- By:
- Publication type:
- Article
Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 69, doi. 10.1007/s00280-015-2775-y
- By:
- Publication type:
- Article
Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 211, doi. 10.1007/s00280-015-2776-x
- By:
- Publication type:
- Article
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with F-3′deoxy-3′fluoro- l-thymidine positron emission tomography/computed tomography.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 187, doi. 10.1007/s00280-015-2779-7
- By:
- Publication type:
- Article
Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 125, doi. 10.1007/s00280-015-2778-8
- By:
- Publication type:
- Article
Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 141, doi. 10.1007/s00280-015-2774-z
- By:
- Publication type:
- Article
Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 133, doi. 10.1007/s00280-015-2780-1
- By:
- Publication type:
- Article
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
- Published in:
- 2015
- By:
- Publication type:
- Report
Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 155, doi. 10.1007/s00280-015-2784-x
- By:
- Publication type:
- Article
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 61, doi. 10.1007/s00280-015-2744-5
- By:
- Publication type:
- Article
Erratum to: Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
- Published in:
- 2015
- By:
- Publication type:
- Erratum